PHYTOCHEMICALS AND COMPLICATIONS IN TYPE 2 DIABETES-AN UPDATE

被引:6
|
作者
Oza, Manisha J. [1 ,2 ]
Kulkarni, Yogesh A. [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Bombay 400056, Maharashtra, India
[2] SVKMs Dr Bhanuben Nanavati Coll Pharm, Bombay, Maharashtra, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2016年 / 7卷 / 01期
关键词
Cardiovascular Diseases; Nephropathy; Neuropathy; Peripheral Artery Diseases; Phytoconstituents; Retinopathy; Type; 2; Diabetes;
D O I
10.13040/IJPSR.0975-8232.7(1).14-24
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Type 2 diabetes is a serious health problem globally. In type 2 diabetes insulin resistance in various tissues such as liver, muscle and beta-cell is the major pathophysiological defects. People with long term uncontrolled hyperglycemia are at risk of developing a number of serious and life-threatening complications which mainly affect the heart and blood vessels, eyes, kidneys, and nerves. Current drug development strategy has focused towards the control of hyperglycemia but the treatment of severe complications has been neglected. Many herbs including Momordica charantia, Coccinia indica, Ficus carica, Gymnema sylvestre, Ocimum santum and many more have traditionally been used for the treatment of diabetes and associated complications. Natural products have been reported to have their efficacy in diabetes and its complications by protecting pancreatic beta-cells, increasing insulin sensitivity, reducing oxidative stress and by targeting various proteins. Thus, now a day plant based natural product (phytoconstituents) have been the basis of drug development program for the treatment of various diseases. The present review summarizes the latest updates on phytochemicals from different class of secondary metabolites with potential effect in type 2 diabetic complications.
引用
收藏
页码:14 / 24
页数:11
相关论文
共 50 条
  • [41] Screening for type 2 diabetes: an update of the evidence
    Simmons, R. K.
    Echouffo-Tcheugui, J. B.
    Griffin, S. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (10): : 838 - 844
  • [42] Obesity and type 2 diabetes (Update 2023)
    Clodi, Martin
    Toplak, Hermann
    Resl, Michael
    Brix, Johanna
    Leitner, Deborah Raphaela
    Harreiter, Juergen
    Hoppichler, Friedrich
    Wascher, Thomas C.
    Schindler, Karin
    Ludvik, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (SUPPL 1) : 91 - 97
  • [43] Management of Type 2 diabetes in youth: An update
    Peterson, Kevin
    Silverstein, Janet
    Kaufman, Francine
    Warren-Boulton, Elizabeth
    AMERICAN FAMILY PHYSICIAN, 2007, 76 (05) : 658 - 664
  • [44] CE: Type 2 Diabetes: A Pharmacologic Update
    Keresztes, Patricia
    Peacock-Johnson, Annette
    AMERICAN JOURNAL OF NURSING, 2019, 119 (03) : 32 - 40
  • [45] Update: vildagliptin for the treatment of Type 2 diabetes
    Garber, Alan J.
    Sharma, Morali D.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (01) : 105 - 113
  • [46] Type 2 Diabetes Mellitus and Hypertension: An Update
    Lastra, Guido
    Syed, Sofia
    Kurukulasuriya, L. Romayne
    Manrique, Camila
    Sowers, James R.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (01) : 103 - +
  • [47] Sitagliptin for Type 2 diabetes: a 2015 update
    Lee, Maria
    Rhee, Mary K.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 597 - 610
  • [48] Update on Insulin Therapy for Type 2 Diabetes
    Donner, Thomas
    Munoz, Miguel
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1405 - 1413
  • [49] Assessing Fear of Complications in People With Type 1 and Type 2 Diabetes With the Fear of Diabetes Complications Questionnaire
    Schmitt, Andreas
    Ehrmann, Dominic
    Kuniss, Nadine
    Mueller, Nicolle
    Kulzer, Bernhard
    Hermanns, Norbert
    HEALTH PSYCHOLOGY, 2023, 42 (09) : 674 - 685
  • [50] Update on vitamin D and type 2 diabetes
    Maxwell, Christy S.
    Wood, Richard J.
    NUTRITION REVIEWS, 2011, 69 (05) : 291 - 295